Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

Not because FDA dictates EMA -
but because once the U.S. steps first, the risk of being wrong disappears for Europe.
And that is the core insight:
EMA hesitated not because the drug is weak - but because being first carries political and financial risk.
If a drug can’t swim, it sinks. They could not sink it after 210 days.

So...bureaucratic CYA is exactly what is sinking us under your thesis. My biggest worry.
That said, they have nothing submitted to the FDA, so expecting them to be first approver is wrong.
It's either that the ABCLEAR data allows the EMA to grow a pair....or we fail.